InspireMD (OTC:NSPR) said it added some $23 million to its coffers in a public stock offering.
The Tel Aviv-based medical device company makes the MGuard device, designed to protect against embolism after stenting procedures.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
MASSDEVICE ON CALL — Pennsylvania Hospital has remained rather closed-lipped about the excess stenting scandal that resulted in the resignation of one of its cardiologists, but at least 1 patient sprang to the defense of accused cardiologist Dr. Vidya Banka.
The doctor is under investigation by the hospital over "concerns about the appropriateness of some cardiac stent placements," according to a Pennsylvania Hospital statement.
Johnson & Johnson (NYSE:JNJ) logged a major win for its Cordis stent-making arm today when a federal appeals court overturned a lower court decision to award more than $593 million to stent pioneer Dr. Bruce Saffran for patent infringement.
Saffran alleged that Cordis violated his patent with the Cypher drug-eluting stent, leading to a jury trial that went Saffran’s way.
InspireMD (OTC:NSPR) said it won a nod from European regulators for its MGuard embolic protection stent, designed to prevent strokes after carotid artery stenting procedures.
The Tel-Aviv-based medical device company said the MGuard device is wrapped with its MicroNet mesh to prevent embolisms – blood clots – from occurring during and after the placement of a carotid stent.
OrbusNeich continued its global row against medtech titan Boston Scientific (NYSE:BSX) even further, filing a patent infringement lawsuit in Ireland to join ones pending in Germany and the Netherlands.
St. Jude Medical (NYSE:STJ) said its launched the Ilumien Optis device in Japan, calling it the only medical device on the market to combine fractional flow reserve and optical coherence tomography technology to allow doctors to evaluate the state and severity of coronary lesions.
OrbusNeich is taking a recent patent infringement win against Boston Scientific (NYSE:BSX) even further, filing lawsuits in both Germany and the Netherlands to allege patent infringement over stent technology.